Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model

Schistosomiasis threatens 800 million people worldwide. Chronic pathology manifests as hepatosplenomegaly, and intestinal schistosomiasis caused by Schistosoma mansoni can lead to liver fibrosis, cirrhosis, and blood in the stool. To assist the only FDA-approved drug, praziquantel, in parasite elimi...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Dilhan J. Perera, Adam S. Hassan, Yimei Jia, Alessandra Ricciardi, Michael J. McCluskie, Risini D. Weeratna, Momar Ndao
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2020-11-01
Σειρά:	Frontiers in Immunology
Θέματα:	Schistosoma mansoni schistosomiasis vaccine adjuvant archaeosomes AddaVax
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.605288/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!